Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Elan to Move ELND005 to Phase III
Elan to Move ELND005 to Phase III
Elan to Move ELND005 to Phase III
Submitted by
admin
on August 16, 2010 - 4:26pm
Source:
Yahoo/Zacks.com
News Tags:
Elan
clinical trials
JNJ
Alzheimer's disease
Transition Therapeutics
Forest Labs
Headline:
Elan to Move ELND005 to Phase III
Do Not Allow Advertisers to Use My Personal information